Article

Anti-open access bill is back

A bill aimed at undoing the NIH's mandate to make federally-funded research manuscripts freely available on PubMed Central within a year of publication was re-introduced in the US House of Representatives on Tuesday night (Feb. 3). The legislation claims that the NIH policy breaches existing copyright laws that protect academic publishers. If passed, the bill would stop federal agencies from requiring the transfer of copyright as a stipulation of investigators receiving taxpayer-backed grants.

Written byElie Dolgin
| 2 min read
Save for Later
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A bill aimed at undoing the NIH's mandate to make federally-funded research manuscripts freely available on PubMed Central within a year of publication was re-introduced in the US House of Representatives on Tuesday night (Feb. 3). The legislation claims that the NIH policy breaches existing copyright laws that protect academic publishers. If passed, the bill would stop federal agencies from requiring the transfer of copyright as a stipulation of investigators receiving taxpayer-backed grants. The details of the bill, HR 801, have not yet been made public, but the__ linkurl:Library Journal;http://www.libraryjournal.com/article/CA6634646.html __reports that those who have seen the legislation say it reads along the same lines as last year's version, dubbed the __Fair Copyright in Research Works Act__ (HR 6845). That bill, which was championed by linkurl:John Conyers;http://conyers.house.gov/ (D-Mich), the chairman of the linkurl:US House Committee on the Judiciary;http://judiciary.house.gov/ and an avowed critic of the NIH's public access mandate, was the focus of a linkurl:spirited debate;http://www.the-scientist.com/blog/display/55009/ at a House Judiciary Subcommittee last September as supporters in the publishing industry squared off against advocates of open-access. The linkurl:Association of American Publishers;http://www.publishers.org/ welcomed the bill's reintroduction, and said in a linkurl:statement;http://www.publishers.org/main/PressCenter/Archicves/2009_Feb/02_FairCopyright.htm that the legislation "would help keep the Federal Government from undermining copyright protection for journal articles where private-sector publishers have added such significant value." The linkurl:Copyright Alliance,;http://www.copyrightalliance.org/ an advocacy group, also backed the measure. "This bipartisan bill ensures that research works fully funded by the federal government with the intent of public publishing will receive that treatment, but also preserves the rights of other research funders and publishers," said executive director Patrick Ross in a linkurl:statement.;http://www.copyrightalliance.org/news.php?id=59 linkurl:Peter Suber,;http://www.earlham.edu/~peters/ an open-access proponent at Earlham College in Richmond, Indiana, wrote on his linkurl:Open Access News blog;http://www.earlham.edu/~peters/fos/fosblog.html yesterday that he dismisses the bill's premise and the arguments of the two publisher groups as "false and cynical." "If the NIH policy violated copyrights, or permitted the violation of copyrights, publishers wouldn't have to back this bill to amend US copyright law. Instead, they'd be in court where they'd already have a remedy," he wrote. __Correction: An earlier version of this story incorrectly stated Peter Suber's affiliation.__ The Scientist__ regrets the error.__
**__Related stories:__***linkurl:Open access recall?;http://www.the-scientist.com/blog/display/55009/
[12th September 2008]*linkurl:Hearing on open access mandate?;http://www.the-scientist.com/blog/display/55004/
[5th September 2008]*linkurl:Publishers object to OA mandate;http://www.the-scientist.com/blog/display/54088/
[4th January 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Join for free today
Already a member? Login Here

Meet the Author

Share

Related Research Resources

The Scientist Placeholder Image

Exploring Organoids for Disease Modeling Research

Webinar

The Scientist Placeholder Image

From Bench to Startup

Webinar

Emerging Therapeutic Strategies in Oncology

Emerging Therapeutic Strategies in Oncology

Webinar

Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Webinar

Stemcell Technologies
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Product News

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies